Percutaneous radiofrequency ablation: minimally invasive therapy for renal tumors

References

• Novick AC, Campbell SC. Renal Tumors. In: Campbell’s Urology, 8th Edition. Walsh PC, Retik AB, Vaughan ED Jr, Wein EJ (Eds). Saunders, NY, USA, 2672–2731 (2002).
   Google Scholar
• Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J. Urol.166(5), 1611–1623 (2001).
   PubMed Web of Science ®Google Scholar
• Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA281(17), 1628–1631 (1999).
   PubMed Web of Science ®Google Scholar
• Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J. Urol.101(3), 297–301 (1969).
   PubMed Web of Science ®Google Scholar
• Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J. Urol.166(1), 6–18 (2001).
   PubMed Web of Science ®Google Scholar
• Lightfoot N, Conlon M, Kreiger N et al. Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur. Urol.37(5), 521–527 (2000).
   PubMed Web of Science ®Google Scholar
• Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology51(2), 203–205 (1998).
   PubMed Web of Science ®Google Scholar
• Ficarra V, Novara G, Galfano A et al. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability? Urology63(6), 1050–1054 (2004).
   Google Scholar
• Spaliviero M, Moinzadeh A, Gill IS. Laparoscopic cryotherapy for renal tumors. Technol. Cancer Res. Treat.3(2), 177–180 (2004).
   Google Scholar
• Gill IS, Remer EM, Hasan WA et al. Renal cryoablation: outcome at 3 years. J. Urol.173(6), 1903–1907 (2005).
   PubMed Web of Science ®Google Scholar
• Gervais DA, McGovern FJ, Wood BJ et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology217(3), 665–672 (2000).
   PubMed Web of Science ®Google Scholar
• Shingleton WB, Sewell PE Jr. Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J. Urol.165(3), 773–776 (2001).
   PubMed Web of Science ®Google Scholar
• Silverman SG, Tuncali K, vanSonnenberg E et al. Renal tumors: MR imaging-guided percutaneous cryotherapy – initial experience in 23 patients. Radiology236(2), 716–724 (2005).
   PubMed Web of Science ®Google Scholar
• Gupta A, Allaf ME, Kavoussi LR et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J. Urol.175(2), 447–452; discussion 452–443 (2006).
   PubMed Web of Science ®Google Scholar
• Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am. J. Roentgenol.185(1), 64–71 (2005).
   PubMed Web of Science ®Google Scholar
• Farrell MA, Charboneau WJ, DiMarco DS et al. Imaging-guided radiofrequency ablation of solid renal tumors. Am. J. Roentgenol.180(6), 1509–1513 (2003).
   PubMed Web of Science ®Google Scholar
• Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology61(4 Suppl. 1), 26–33 (2003).
   PubMed Web of Science ®Google Scholar
• Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. Am. J. Roentgenol.180(6), 1503–1508 (2003).
   Google Scholar
• Ahrar K, Matin S, Wood CG et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J. Vasc. Interv. Radiol.16(5), 679–688 (2005).
   Google Scholar
• Clark TW, Malkowicz B, Stavropoulos SW et al. Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. J. Vasc. Interv. Radiol.17(3), 513–519 (2006).
   Google Scholar
• Pavlovich CP, Walther MM, Choyke PL et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J. Urol.167(1), 10–15 (2002).
   PubMed Web of Science ®Google Scholar
• Zagoria RJ, Hawkins AD, Clark PE et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. Am. J. Roentgenol.183(1), 201–207 (2004).
   PubMed Web of Science ®Google Scholar
• Veltri A, De Fazio G, Malfitana V et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur. Radiol.14(12), 2303–2310 (2004).
   Google Scholar
• Mahnken AH, Rohde D, Brkovic D, Gunther RW, Tacke JA. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results. Acta Radiol.46(2), 208–214 (2005).
   Web of Science ®Google Scholar
• Ogan K, Jacomides L, Dolmatch BL et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology60(6), 954–958 (2002).
   PubMedGoogle Scholar
• Roy-Choudhury SH, Cast JE, Cooksey G, Puri S, Breen DJ. Early experience with percutaneous radiofrequency ablation of small solid renal masses. Am. J. Roentgenol.180(4), 1055–1061 (2003).
   Google Scholar
• Lewin JS, Nour SG, Connell CF et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology232(3), 835–845 (2004).
   PubMed Web of Science ®Google Scholar
• de Baere T, Kuoch V, Smayra T et al. Radio frequency ablation of renal cell carcinoma: preliminary clinical experience. J. Urol.167(5), 1961–1964 (2002).
   Google Scholar
• Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities – part I. J. Vasc. Interv. Radiol.12(9), 1021–1032 (2001).
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Dawson SL et al. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad. Radiol.2(5), 399–404 (1995).
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Hahn PF, Tanabe KK et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J. Vasc. Interv. Radiol.9(1 Pt 1), 101–111 (1998).
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Dawson SL et al. Tissue ablation with radiofrequency using multiprobe arrays. Acad. Radiol.2(8), 670–674 (1995).
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad. Radiol.3(8), 636–644 (1996).
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Stein MC, Gazelle GS et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J. Vasc. Interv. Radiol.10(7), 907–916 (1999).
   PubMed Web of Science ®Google Scholar
• Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology197(3), 589–597 (1995).
   PubMed Web of Science ®Google Scholar
• Oda T, Miyao N, Takahashi A et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int. J. Urol.8(9), 473–477 (2001).
   PubMed Web of Science ®Google Scholar
• Wehle MJ, Thiel DD, Petrou SP et al. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology64(1), 49–52 (2004).
   PubMed Web of Science ®Google Scholar
• Rendon RA, Stanietzky N, Panzarella T et al. The natural history of small renal masses. J. Urol.164(4), 1143–1147 (2000).
   PubMed Web of Science ®Google Scholar
• Kato M, Suzuki T, Suzuki Y et al. Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J. Urol.172(3), 863–866 (2004).
   PubMed Web of Science ®Google Scholar
• Wood BJ, Grippo J, Pavlovich CP. Percutaneous radio frequency ablation for hematuria. J. Urol.166(6), 2303–2304 (2001).
   Google Scholar
• McLaughlin CA, Chen MY, Torti FM, Hall MC, Zagoria RJ. Radiofrequency ablation of isolated local recurrence of renal cell carcinoma after radical nephrectomy. Am. J. Roentgenol.181(1), 93–94 (2003).
   Google Scholar
• Ahrar K, Matin S, Wallace MJ, Gupta S, Hicks ME. Percutaneous transthoracic radiofrequency ablation of renal tumors using an iatrogenic pneumothorax. Am. J. Roentgenol.185(1), 86–88 (2005).
   PubMed Web of Science ®Google Scholar
• Farrell MA, Charboneau JW, Callstrom MR et al. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. Am. J. Roentgenol.181(5), 1315–1317 (2003).
   PubMed Web of Science ®Google Scholar
• Kariya S, Tanigawa N, Kojima H et al. Radiofrequency ablation combined with CO2 injection for treatment of retroperitoneal tumor: protecting surrounding organs against thermal injury. Am. J. Roentgenol.185(4), 890–893 (2005).
   PubMed Web of Science ®Google Scholar
• Yamakado K, Nakatsuka A, Akeboshi M, Takeda K. Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J. Vasc. Interv. Radiol.14(9 Pt 1), 1183–1186 (2003).
   PubMed Web of Science ®Google Scholar
• Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin. Urol. Oncol.13(4), 254–261 (1995).
   PubMedGoogle Scholar
• Chawla SN, Crispen PL, Hanlon AL et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol.175(2), 425–431 (2006).
   PubMed Web of Science ®Google Scholar
• Tuncali K, van Sonnenberg E, Shankar S et al. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. Am. J. Roentgenol.183(3), 575–582 (2004).
   PubMed Web of Science ®Google Scholar
• Zlotta AR, Wildschutz T, Raviv G et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J. Endourol.11(4), 251–258 (1997).
   PubMed Web of Science ®Google Scholar
• McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radio frequency ablation of renal cell carcinoma via image guided needle electrodes. J. Urol.161(2), 599–600 (1999).
   Google Scholar
• Gettman MT, Lotan Y, Corwin TS et al. Radiofrequency coagulation of renal parenchyma: comparison of effects of energy generators on treatment efficacy. J. Endourol.16(2), 83–88 (2002).
   Google Scholar
• Margulis V, Matsumoto ED, Lindberg G et al. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology64(4), 660–663 (2004).
   PubMed Web of Science ®Google Scholar
• Matlaga BR, Zagoria RJ, Woodruff RD, Torti FM, Hall MC. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J. Urol.168(6), 2401–2405 (2002).
   Google Scholar
• Rendon RA, Kachura JR, Sweet JM et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J. Urol.167(4), 1587–1592 (2002).
   PubMedGoogle Scholar
• Michaels MJ, Rhee HK, Mourtzinos AP et al. Incomplete renal tumor destruction using radio frequency interstitial ablation. J. Urol.168(6), 2406–2409; discussion 2409–2410 (2002).
   PubMed Web of Science ®Google Scholar
• Varkarakis IM, Allaf ME, Inagaki T et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J. Urol.174(2), 456–460; discussion 460 (2005).
   PubMed Web of Science ®Google Scholar
• McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J. Urol.174(1), 61–63 (2005).
   PubMedGoogle Scholar
• Roach H, Whittlestone T, Callaway MP. Life-threatening hematuria requiring transcatheter embolization following radiofrequency ablation of renal cell carcinoma. Cardiovasc. Intervent. Radiol.29(4), 672–674 (2006).
   Google Scholar
• Johnson DB, Saboorian MH, Duchene DA, Ogan K, Cadeddu JA. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology62(2), 351–352 (2003).
   PubMed Web of Science ®Google Scholar
• Johnson DB, Taylor GD, Lotan Y et al. The effects of radio frequency ablation on renal function and blood pressure. J. Urol.170(6 Pt 1), 2234–2236 (2003).
   Google Scholar
• Weizer AZ, Raj GV, O’Connell M et al. Complications after percutaneous radiofrequency ablation of renal tumors. Urology66(6), 1176–1180 (2005).
   Google Scholar
• Boss A, Clasen S, Kuczyk M et al. Thermal damage of the genitofemoral nerve due to radiofrequency ablation of renal cell carcinoma: a potentially avoidable complication. Am. J. Roentgenol.185(6), 1627–1631 (2005).
   Google Scholar
• Bhayani SB, Allaf ME, Su LM, Solomon SB. Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. Urology65(3), 592 (2005).
   Google Scholar
• Lotan Y, Cadeddu JA. A cost comparison of nephron-sparing surgical techniques for renal tumour. Br. J. Urol. Int.95(7), 1039–1042 (2005).
   Google Scholar
• Gervais D, Arellano R, Mueller P. Percutaneous ablation of kidney tumors in nonsurgical candidates. Oncology19(11 Suppl. 4), 6–11 (2005).
   Google Scholar